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Association between transforming growth factor beta-1 gene (TGFB1) 869T/C polymorphism and hypertension has been widely
evaluated,yetwithconﬂictingresults.Asmeta-analysisisareliablewaytoresolvediscrepancies;Iaimedtoevaluatethisassociation.
Data were available from 9 study populations involving 6151 subjects. Overall, comparison of allele 869C with 869T generated
a signiﬁcant 30% increased hypertension risk (95% conﬁdence interval [95%CI]: 1.11–1.51; P = 0.001), which was strengthened
for homozygous comparison (869CC versus 869TT) with odds ratio (OR) doubled to 1.62 (95%CI: 1.23–2.14; P = 0.001).
Stratiﬁed analysis by study design demonstrated stronger associations in population-based studies than in hospital-based
studies with OR, except in the dominant model, being increased by 7.94–18.61%. Likewise, ethnicity-based analysis exhibited
a contradictory association between Asians and Whites. Conclusively, these ﬁndings support the notion that TGFB1 gene 869T/C
polymorphism may inﬂuence the risk of hypertension, especially in Asian populations.
1.Introduction
Hypertension is a complex multifactorial disorder with mas-
ses of genetic and environmental factors contributing to its
occurrence [1]. Although great eﬀort has been devoted to
uncover the genetic underpinnings of hypertension, there is
no deﬁnite consensus on how many genes and which genetic
determinants are actually involved in its development.
Currently, evidence that links inﬂammation to the gen-
esis of hypertension is proliferating [2, 3]. As an anti-
inﬂammatory regulator, transforming growth factor beta-1
or TGF-β1( g e n e :TGFB1) plays a part in many diﬀerent
clinical processes, such as embryonal development, cellular
proliferation and diﬀerentiation, wounding healing, and
angiogenesis [4, 5]. In addition, augmented production of
TGF-β1, partly via the mediation of angiotensin II, poten-
tially contributes to target organ damage related to hyper-
tension [6–9].
Since the genomic sequence of TGFB1 gene is highly pol-
ymorphic, it is of added interest to conﬁrm which TGFB1
polymorphism(s) might have functional potentials to inﬂu-
ence the ﬁnal bioavailability of TGF-β1, thus the develop-
ment of hypertension. In particular, an exonic polymor-
phism, 869T/C (rs1982073) in TGFB1 gene, has been studied
extensively; however, the results are not often reproducible
with positive signals being reported in some [10], but not
all [11, 12], studies. Generally, association studies with in-
dividually low statistical power might account for this lack of
consistency [13].
As meta-analysis is a reliable way to resolve discrepancies
in association studies and in an eﬀort to clarify earlier in-
conclusive results, I decided to evaluate the inﬂuence of
TGFB1 gene869T/Cpolymorphism ontheoccurrenceofhy-
pertension,whileaddressingbetween-studyheterogeneity,as
well as publication bias.2 International Journal of Hypertension
2. Methods
2.1. Literature Search. Both English and Chinese language
publications were identiﬁed using PubMed and EMBASE
engines, as well as China Biological Medicine (http://sinom-
ed.imicams.ac.cn/index.jsp) and Wanfang (http://www.wan-
fangdata.com.cn) databases with the deadline at February
1, 2011. Keywords used for search in the Boolean expres-
sion were (transforming growth factor beta-1 OR TGF-
β1 OR TGFB1) AND (hypertension OR blood pressure)
AND (polymorphism OR allele OR genotype OR variant
OR variation). Searching results were limited to human
populations (rather than family-based populations). The
full text of the retrieved articles was scrutinized to decide
whetherinformationonthetopicofinterestwasincluded.In
addition, reference lists of the retrieved articles and reviews
were also checked for citations of publications that were not
initially identiﬁed. If more than one geographic or ethnic
groups were included in one publication, each group was
treated separately.
2.2. Inclusion/Exclusion Criteria. Qualiﬁed studies in this
meta-analysis met the following criteria: (i) evaluation of the
TGFB1 gene 869T/C polymorphism with hypertension; (ii)
case-control or cross-sectional study using either a hospital-
based or population-based design; (iii) suﬃcient infor-
mation on 869T/C genotype counts between hypertensive
patients and controls for estimating odds ratio (OR) and its
corresponding 95% conﬁdence interval (95% CI).
Hypertension was deﬁned as systolic blood pressure
equal to or above 140mmHg or diastolic blood pressure
equal to or above 90mmHg or previous treatment with anti-
hypertensive drugs. Studies evaluating secondary hyper-
tension or other types of monogenic hypertension were
excluded. Where there were multiple publications from the
same study population, the most complete and recent results
were extracted.
2.3. Extracted Information. The following information was
extractedfromeachqualiﬁedstudy:ﬁrstauthor’sname,pub-
lication date, population ethnicity, study design, diagnostic
criteria,baselinecharacteristicsofthestudypopulation(such
as age, gender, and body mass index), and the 869T/C
genotype counts in patients and controls. For consistency,
continuous variables expressed as mean ± standard error
(SE) were converted to mean ± standard deviation (SD).
Moreover, the units of measures used in this study are
transformed into the standard measurement units. Data and
study quality were assessed in duplicate.
2.4. Statistical Analysis. In this meta-analysis, I assessed the
association of TGFB1 gene 869C allele with hypertension
relative to the 829T allele (allelic model), as well as the
homozygous contrast (869CC versus 869TT), the dominant
model (869CC plus 869TC versus 869TT), and the recessive
model (869CC versus 869TT plus 869TC). Unadjusted OR
and 95% CI were used to compare contrasts of alleles
or genotypes between patients and controls. The random-
eﬀects model using the method of DerSimonian & Laird,
instead of ﬁxed-eﬀects model, was implemented to bring the
individual eﬀect-size estimates together, and the estimate of
heterogeneity was taken from the Mantel-Haenszel model
[14].
Satisfaction of 869T/C genotypes with Hardy-Weinberg
proportions was calculated using the χ2 test or Fisher’s
exact test in control groups. Between-study heterogeneity
was assessed by the inconsistency index I2 statistic (ranging
from 0 to 100%), which was documented for the percentage
of the observed between-study variability due to hetero-
geneity rather than chance, with higher values of this index
suggesting the existence of heterogeneity [15, 16]. In the
case of between-study heterogeneity, I examined the study
characteristics that can stratify the studies into subgroups
with homogeneous eﬀects.
Cumulative meta-analysis was conducted to identify the
inﬂuence of the ﬁrst published study on the subsequent
publications and the evolution of the combined estimates
overtimeaccordingtotheascendingdateofpublication[17].
Likewise to identify potentially inﬂuential studies, sensitivity
analysis was undertaken by removing an individual study
each time to check whether any of these estimates can bias
the overall estimate.
Additionally, to estimate the extent to which one or
more covariates explain heterogeneity, metaregression, as an
extension to random-eﬀects meta-analysis, was employed.
The metaregression model relates the treatment eﬀect to the
study-level covariates including averaged values of age, male
percent, body mass index (BMI), glucose, triglyceride (TG),
total cholesterol (TC), high-density lipoprotein cholesterol
(HDLC), and low-density lipoprotein cholesterol (LDLC)
between patients and controls, as well as the study design
(population-based design versus hospital-based design) and
ethnicity (Asians versus Whites).
I used the funnel plots and Egger regression asymmetry
test to examine publication bias. Egger’s test can detect
funnel plot asymmetry by determining whether the intercept
deviates signiﬁcantly from zero in a regression of the
standardized eﬀect estimates against their precision [18].
Probability less than 0.05 was judged as signiﬁcant
with the exception of the I2 statistic and publication test,
where a signiﬁcance level of less than 0.1 was chosen. Data
management and statistical analyses were performed using
STATA version 11.0 for Windows.
3. Results
3.1. Description of Available Studies. The initial literature
search yielded 66 publications. Further application of the
identiﬁcation criteria left 8 published papers [10–12, 19–
23] involving 9 study populations (case-patients/controls:
2747/3404) in an attempt to evaluate the association of
TGFB1 gene 869T/C polymorphism with hypertension.
Thereof, three papers were written in English language [10–
12], and the remaining in Chinese language. The study aims
and main results of Chinese language reports are presentedInternational Journal of Hypertension 3
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Figure 1: Overall risk estimates of TGFB1 gene 869T/C polymorphism for hypertension in the allelic (a), homozygous (b), dominant (c),
and recessive (d) models.
in Supplementary Table 1 (see Table 1 in Supplementary
Materialavailableonlineatdoi:10.4061/2011/934265). Seven
populations included Chinese subjects [10, 19–23], one
included Japanese subjects [11], and one included White
population [12]. Except one study [12] involving patients
with both hypertension and rheumatoid arthritis, others
were focusing on essential hypertension patients. The base-
line characteristics of the study populations are summarized
in Table 1.
Genotyping for 869T/C polymorphism in all qualiﬁed
studies, except one [12] using Roche LightCycler method,
was conducted using polymerase chain reaction-restriction
fragment length polymorphism (PCR-RFLP) followed by
enzyme digestion. The frequencies of 869C allele in the
case/control groups were 0.527/0.457 in all populations and
were exceedingly low (0.347/0.367) in Whites. Taking into
accountonlythecontrolgroups,genotypedistributionswere
in Hardy-Weinberg equilibrium across all studies.
3.2. Overall Analysis. In allelic model, comparison of the
mutant 869C allele with the wild 869T allele generated
a signiﬁcant 30% increased risk for hypertension (95%
CI: 1.11–1.51; P = 0.001), yet with strong evidence of
between-study heterogeneity (I2 = 72.4%; P<0.0005)
(Figure 1). Besides the suggestive symmetry of funnel plot
(Figure 2), Egger’s test indicated no publication bias (P =
0.25). Further, this association was potentially strengthened
in the homozygous comparison (869CC versus 869TT) with
OR nearly doubled to 1.62 (95% CI: 1.23–2.14; P = 0.001).
Similarly, this association was still tingled by signiﬁcant
heterogeneity (I2 = 66.2%; P = 0.003), the risk estimates
from individual studies were symmetric (Figure 2), and the
Egger’s test suggested a low probability of publication bias
(P = 0.262).
Additionally, in view of the heterozygous 869TC geno-
type, I considered two diﬀerent models of inheritance.
Overall, the ORs from allelic model were almost similar
in magnitude from both dominant (OR = 1.35; 95% CI:
1.11–1.64; P = 0.003) and recessive (OR = 1.41; 95%
CI: 1.16–1.71; P<0.0005) models (Figure 1). Although
between-study heterogeneity was attenuated to a certain
extent, statistical tests still reached signiﬁcance (dominant:
I2 = 57.4%; P = 0.016; recessive: I2 = 53.0%; P =
0.03). Moreover, there was evident publication bias only in
dominantmodelasreﬂectedbythefunnelplotandstatistical
test (P = 0.06).
3.3. Cumulative and Sensitivity Analyses. In the cumulative
meta-analysis, there was no evidence suggesting the ﬁrst
published study that reported a potentially signiﬁcant result4 International Journal of Hypertension
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Figure 2: Funnel plots for studies investigating the eﬀect of TGFB1 gene 869T/C polymorphism on the risk of hypertension across the allelic
(a), homozygous (b), dominant (c), and recessive (d) models. Vertical axis represents the log of OR; horizontal axis represents the SE of
log(OR). Funnel plots are drawn with 95% conﬁdence limits. OR, odds ratio; SE, standard error. The graphic symbols represent the data in
the plot sized proportional to the inverse variance.
and then trigged the subsequent replication. Also generally
the sensitivity analysis revealed that no single studies were
observed to inﬂuence the pooled results signiﬁcantly (data
not shown).
3.4.SourcesofHeterogeneity. Consideringthesigniﬁcanthet-
erogeneity in the above comparisons, I considered it a better
choice to try investigating its sources by ﬁrst conducting
subgroup analyses in homogeneous groups and then incor-
porating various study-level covariates in a metaregression
model. To evaluate the possible eﬀect of study design on
the variability of overall estimates, studies were divided
into population based and hospital based, and importantly
the magnitude of association in population-based studies
was gradiently potentiated in 869T/C allelic (OR increased
by 7.94%), homogeneous (10.13%), and recessive (18.61%)
models compared with that in hospital-based studies (Fig-
ure 3).
Further ethnicity-stratiﬁed analysis indicated strik-
ingly heterogeneous associations of 869T/C polymorphism
with hypertension, by showing a contradictory associa-
tion between Asians and Whites (Figure 4). In Asians,
I consistently observed a risk-conferring eﬀect of the 869C
allele or 869CC genotype for hypertension, even upon
stratiﬁcation by countries, as well as Chinese ethnic groups.
Contrastingly, after restricting analysis to Whites, although
there was just one study [12], I hereto observed a protective
eﬀect (OR = 0.84–0.92), and the corresponding wide con-
ﬁdence intervals in all genetic models gave an indication of
insuﬃcient study power in White populations.
After metaregressing the explanatory variables of interest
in this study (see Section 2.4), I unfortunately failed to
detect any statistical signiﬁcance concerning 869T/C poly-
morphism across all genetic models (data not shown).
4. Discussion
Via a comprehensive evaluation of TGFB1 gene 869T/C
polymorphism among 6151 subjects, I provided for the ﬁrst
time convincing evidence that individuals homozygous for
the 869C allele were 62% more likely to develop hyperten-
sion with respect to homozygous for the 869TT subjects.
Although between-study heterogeneity, albeit disturbing,
could not be easily eliminated, this study indicated that
TGFB1 gene could be a genetic marker for hypertension.6 International Journal of Hypertension
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Figure 3: Stratiﬁed analysis of TGFB1 gene 869T/C polymorphism by study design with hypertension in the allelic (a), homozygous (b),
dominant (c), and recessive (d) models.
In this meta-analysis, study design and ethnicity were
regarded as potential sources of between-heterogeneity by
subgroup but not metaregression analyses. Although I only
focused on nine populations, which runs the risk of false-
positive ﬁndings, my results can still drop several hints here.
Firstly, subgroup analysis indicated that magnitude of asso-
ciation was potentially strengthened in population-based
studies relative to in hospital-based studies. I agree that
control for population stratiﬁcation remains an important
consideration in hospital-based studies [24], because in this
meta-analysis,moststudieshaverecruitedsubjectsfromonly
one hospital, and thus there might be a narrow socioe-
conomic proﬁle for both patients and controls. Moreover,
in hospital-based studies, poor comparability between cases
and controls might exert a confounding eﬀect on the true
association in light of a regional specialty for the disease
understudyandthediﬀerentialhospitalizationratesbetween
cases and controls [25]. In contrast, subjects drawn from
community or a ﬁxed group might be representative of
the true population, leading us to believe that results from
population-based studies might hold the water. Considering
the wider conﬁdence intervals of estimates and small sample
sizes in population-based studies, more studies are required
to quantify this eﬀect size reliably.
Secondly, remarkable heterogeneous associations of
869T/C polymorphism with hypertension were identiﬁed
across diﬀerent ethnic populations. Several factors might
contribute to this phenomenon. On one hand, hypertension
is a complex disease, and diﬀerent genetic proﬁles may cause
this discrepancy, as indicated by the big diﬀerence of 869C
allele frequencies across diﬀerent populations. In this regard,
it is important to construct a database of genetic variants
related to hypertension in each ethnic group [26]. On the
other hand, this discrepancy is likely due to chance because
there is only one study in Whites, which might be statistically
underpowered to detect a slight eﬀect or may have generated
aﬂuctuatedriskestimate.Itisthusobviousthatmorestudies
are required in subjects of Caucasian descent in order to fully
address this issue.
Thirdly, as an alternative approach to subgroup analysis
andamultivariatemeta-analysis,themetaregressionfailedto
provideanysigniﬁcantsignalsregardingtheallelic/genotypicInternational Journal of Hypertension 7
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Figure 4: Stratiﬁed analysis of TGFB1 gene 869T/C polymorphism by ethnicity with hypertension in the allelic (a), homozygous (b),
dominant (c), and recessive (d) models.
associations of 869T/C polymorphism with hypertension.
However, it is important to bear in mind that metaregression
analysis, although enabling covariates to be considered, does
not have the methodological rigor of a properly designed
study that is intended to test the eﬀect of these covariates
formally [27]. Importantly, one limitation tarnishing this
meta-analysiswasthenumberofstudiesthatareavailablefor
inclusion. In fact, some studies did not report the study-level
covariatesofinterest,precludingamorerobustassessmentof
sources of heterogeneity.
Last but not least, despite the clear strength of this
study including relatively large sample sizes, satisfaction of
Hardy-Weinberg equilibrium, and lack of publication bias,
interpretation of the current study, however, should be
viewed in light of several technical limitations. Because only
published studies were retrieved in this meta-analysis and
the “grey” literature (papers in languages other than English
and Chinese) was not included, publication bias might be
possible, even though the funnel plots and statistical tests
did not show it. In addition, most studies in this meta-
analysis have recruited subjects aged ≥50 years, for whom
environmental factors are likely to contribute more promi-
nently than the genetic component to the development of
hypertension [28], suggesting that large association studies
inayoungerpopulationofhypertensivesubjectsareofadded
interest. Moreover, the single-locus-based nature of meta-
analysis precluded the possibility of gene-gene and gene-
environment interactions, as well as haplotype-based eﬀects,
suggesting that additional studies assessing these aspects
will be necessary. Furthermore, I only centered on TGFB1
gene 869T/C polymorphism and did not covered other
genes or polymorphisms. It seems likely that the 869T/C
polymorphism individually makes a moderate contribution
to risk prediction in hypertensive subjects, but whether
this variant integrated with other risk factors will enhance
the prediction requires additional research. Thus, the jury8 International Journal of Hypertension
must refrain from drawing a conclusion until large, well-
performed studies conﬁrm or refuse this result.
Taken together, I expand previous individual ﬁndings on
hypertension, indicating that the TGFB1 gene 869T/C poly-
morphism may inﬂuence the risk of hypertension, especially
in Asian populations. Also my observation leaves open
the question of heterogeneous eﬀect of 869C allele across
diﬀerent ethnic groups. I believed that this study provides an
anchoringpointforbetterunderstandingofthepathogenesis
of hypertension. Nevertheless, for practical reasons, I hope
that this study will not remain just another endpoint of
research instead of a beginning to establish the background
data for further investigation on mechanisms of the TGFB1
gene and hypertension.
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